Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from

Gallium Radioisotopes Humans Neuroendocrine Tumors / metabolism Octreotide / analogs & derivatives Organometallic Compounds / metabolism Positron Emission Tomography Computed Tomography / methods Prognosis Receptors, Somatostatin Retrospective Studies
68Ga-DOTATOC PET/CT neuroendocrine tumors prognosis somatostatin receptor expressing tumor volume total lesion somatostatin receptor expression tumor burden

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
07 2022
Historique:
received: 28 05 2021
revised: 04 10 2021
pubmed: 7 11 2021
medline: 6 7 2022
entrez: 6 11 2021
Statut: ppublish

Résumé

Our objective was to evaluate the prognostic value of somatostatin receptor tumor burden on

Identifiants

DOI: 10.2967/jnumed.121.262652 PMID: 34740949
pubmed: 34740949
pii: jnumed.121.262652
doi: 10.2967/jnumed.121.262652
doi:

Substances chimiques

Gallium Radioisotopes 0
Organometallic Compounds 0
Receptors, Somatostatin 0
Octreotide RWM8CCW8GP
Edotreotide U194AS08HZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1014-1020

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Philippe Thuillier (P)

Nuclear Medicine Unit, Department of Medical Sciences, University of Turin, Turin, Italy; philippe.thuillier@chu-brest.fr.
Department of Endocrinology, University Hospital of Brest, Brest, France.

Virginia Liberini (V)

Nuclear Medicine Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Serena Grimaldi (S)

Nuclear Medicine Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Osvaldo Rampado (O)

Medical Physics Unit, AOU Città della Salute e della Scienza, Turin, Italy.

Elena Gallio (E)

Medical Physics Unit, AOU Città della Salute e della Scienza, Turin, Italy.

Bruno De Santi (B)

Biolab, Department of Electronics and Telecomunications, Politecnico di Torino, Turin, Italy.

Emanuela Arvat (E)

Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Alessandro Piovesan (A)

Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Roberto Filippi (R)

Departments of Oncology and Medical Sciences, University of Turin, Turin, Italy; and.

Ronan Abgral (R)

Department of Nuclear Medicine, University Hospital of Brest, Brest, France.

Filippo Molinari (F)

Biolab, Department of Electronics and Telecomunications, Politecnico di Torino, Turin, Italy.

Désirée Deandreis (D)

Nuclear Medicine Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Gallium › Isotopes du gallium › Radio-isotopes du gallium › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Octréotide › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Composés chimiques organiques › Composés organométalliques › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Diagnostic › Pronostic › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormones hypothalamiques hypophysotropes régulatrices › Récepteur somatostatine › Prognostic Value of Whole-Body PET Volumetric...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Prognostic Value of Whole-Body PET Volumetric...